ZyVersa Therapeutics ZVSA
OTC ZVSA
$0.00 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

ZyVersa Therapeutics, Inc. (ZVSA) Net Income (2022 - 2026)

Updated

ZyVersa Therapeutics (ZVSA) posted Net Income of -$1.3 million for Q1 2026, compared with -$2.14 million a year earlier.

Analysis

ZyVersa Therapeutics, Inc. (ZVSA) Net Income (2022 - 2026) Analysis & Trends

For the trailing twelve months through Mar 31, 2026, Net Income at ZyVersa Therapeutics was -$24 million; for FY2025, it was -$24.95 million.

  • In prior years, ZyVersa Therapeutics' Net Income was -$9.41 million in FY2024, -$98.3 million in FY2023 and -$14.05 million in FY2022.
  • Quarterly Net Income has run from a low of -$78.51 million in Q2 2023 to a high of -$678,572 in Q4 2025 over five years.
  • According to Business Quant data, Net Income for the three prior quarters was -$678,572 (Q4 2025), -$19.81 million (Q3 2025) and -$2.21 million (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.80 Mn
Dec 31, 2025 -700,000.00
Sep 30, 2025 -19.81 Mn
Jun 30, 2025 -2.21 Mn
Mar 31, 2025 -2.26 Mn
Dec 31, 2024 -1.42 Mn
Sep 30, 2024 -2.40 Mn
Jun 30, 2024 -2.76 Mn
Mar 31, 2024 -2.83 Mn
Dec 31, 2023 -13.34 Mn
Sep 30, 2023 -2.90 Mn
Jun 30, 2023 -78.51 Mn
Mar 31, 2023 -3.54 Mn
Jun 30, 2022 -393,639.00
Mar 31, 2022 -720,006.00
API Access

ZyVersa Therapeutics, Inc. Net Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income&ticker=ZVSA&period=max&api_key=YOUR_API_KEY